According to GlobalData, ANTI-SARS-COV-2 RAPID TEST is one of 108 product lines sold in the US covid-19 tests market; these product lines are sold by 60 different manufacturers. The price of the ANTI-SARS-COV-2 RAPID TEST device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
Smarter leaders trust GlobalData
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Autobio Diagnostics apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Autobio Diagnostics overview
Autobio Diagnostics Co Ltd (Autobio) is a provider of clinical diagnostic products. The company offers its products in the immunoassay, microbiology and biochemistry fields. It offers a full microbiology laboratory solution, covering culture, microbiology identification (ID), antimicrobial susceptibility test (AST) and laboratory information management system (LIMS). The company develops an automated blood culture system BC120. It also develops an automated ID-AST solution, autoMic-i600, for hospital infection control and antibiotic management. Autobio provides phone support and in-field services to its customers. Autobio is headquartered in Zhengzhou, Henan, China.
For a complete picture of ANTI-SARS-COV-2 RAPID TEST, COVID-19 Tests pricing in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
